PCOS Before IVF: Could a One-Hour Glucose Test Reveal Gestational Diabetes Risk Earlier?

A three-center study followed 2,571 women with PCOS after preconception glucose testing.

Normal fasting glucose or a normal body weight did not necessarily rule out metabolic concerns.

For women with polycystic ovary syndrome (PCOS) preparing for IVF, a one-hour glucose result before pregnancy may offer clues to later gestational diabetes risk. A multicenter study found an association between preconception glucose levels and gestational diabetes after conception.

Gestational diabetes is usually diagnosed through testing at 24–28 weeks of pregnancy. The study suggests that glucose testing before IVF may help identify higher-risk women earlier, although it does not establish a new diagnostic threshold or a proven prevention strategy.

Published in the October 2026 issue of Human Reproduction, the research analyzed records from 2,571 women with PCOS treated at three Chinese reproductive medicine centers.

Glucose testing before a first IVF cycle

The women underwent their first IVF treatment between March 2018 and December 2023.

Before treatment, they received a 75-g oral glucose tolerance test: after fasting, they drank a solution containing 75 g of glucose, allowing researchers to assess how blood glucose rose and subsequently fell.

The investigators compared fasting, one-hour and two-hour glucose values with later gestational diabetes, taking account of age, body mass index (BMI) and infertility-related characteristics.

Preconception glucose was associated with subsequent gestational diabetes. The one-hour measurement appeared to provide potentially useful risk information.

Normal fasting glucose does not tell the whole story

Fasting glucose measures blood sugar without recent food intake. It does not necessarily reveal how effectively the body manages glucose after eating.

After a meal, insulin released by the pancreas helps bring glucose down. When this response is less effective, fasting glucose may still appear normal while the rise after a glucose load is excessive.

The researchers reported a significant association with gestational diabetes risk among women whose preconception one-hour glucose was at least 11.6 mmol/L, approximately 209 mg/dL.

This suggests a connection between glucose regulation before pregnancy and the metabolic demands of pregnancy. The value is not a newly established diagnostic cutoff for gestational diabetes, and exceeding it does not mean that gestational diabetes will inevitably develop.

Lean women with PCOS can also have metabolic abnormalities

PCOS is a reproductive endocrine condition commonly involving ovulatory dysfunction. Some affected women have insulin resistance, meaning that insulin is less effective at lowering blood glucose.

Metabolic abnormalities are more common when obesity is also present, but normal body weight does not exclude them.

In analyses by weight category, the association between one-hour glucose and gestational diabetes was evident in normal-weight women and women with obesity. It was not statistically clear in the overweight subgroup.

That finding does not mean overweight women lack gestational diabetes risk. Splitting the population into smaller subgroups can affect statistical precision.

The practical research message is that lean women with PCOS should not be overlooked when considering preconception metabolic assessment.

IVF care also concerns health after conception

During fertility treatment, attention understandably centers on ovulation, follicle growth, egg yield, embryo quality and the uterine lining. Health after pregnancy begins matters as well.

Insulin resistance and altered glucose metabolism in PCOS are associated with greater gestational diabetes risk.

Poorly controlled gestational diabetes can increase risks including excessive fetal growth, preeclampsia and neonatal hypoglycemia. It is also associated with a greater risk of maternal type 2 diabetes after birth.

The source article notes that international PCOS guidance supports considering an oral glucose tolerance test when planning pregnancy or seeking fertility treatment.

The new study adds a possible refinement: examining the one-hour value alongside fasting and two-hour glucose may help characterize risk more closely.

A possible starting point, not a proven prediction or prevention tool

This retrospective observational study identified associations. It did not demonstrate cause and effect or prove that one-hour testing can accurately predict or prevent gestational diabetes.

Further validation is needed before extending the findings to all women receiving fertility treatment.

Nevertheless, preconception glucose testing can be understood as more than screening for existing diabetes: it may help assess health risks that emerge during pregnancy.

A normal body weight does not eliminate the need to consider individual metabolic health in PCOS. When abnormalities are identified, a discussion with the treating team can address appropriate diet, physical activity and weight-management measures before pregnancy.

The aim of IVF is not simply conception but a healthy pregnancy and safe birth. This research points to metabolic assessment before egg retrieval or embryo transfer as one part of that preparation.

Study source

This article is based on a multicenter cohort study in the October 2026 issue of Human Reproduction examining pre-IVF glucose testing and gestational diabetes in 2,571 women with PCOS at three Chinese reproductive medicine centers. DOI: 10.1093/humrep/deag119. The Korean source notes that detailed bibliographic information and numerical findings require checking against the final published paper; they have not been independently verified for this translation.

The illustration was generated using ChatGPT (OpenAI). Any people depicted are fictional.